Novo Nordisk also plans 26 obesity abstracts for ObesityWeek, November 14 to 17, including CagriSema analyses and real-world data on the Wegovy pill.
Recap by typeshit. Full story at ad-hoc-news.de.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
Ahead of results, Kalkine looks at how costly late-stage trials for Amgen's monthly obesity shot MariTide weigh on the outlook.
A short post says demand for GLP-1s, psychedelics and testosterone is meeting commercial interests, calling it a big shift.
A beauty take that waves off pricey LA peptide and salmon sperm serums, saying better anti-aging habits are found closer to home.
50:48
The DOWNSIZED channel answers a question about when people stay on the same GLP-1 dose. Their view, not medical advice, so check with a doctor.
Researchers led by J Petersen and Christoffer Clemmensen at the University of Copenhagen report results from pairing the two obesity drugs. Full findings are in the paper.
Loading…